The producers of public obesity therapy Wegovy and Zepbound cuts people’s prices. Without insurance.
Novo Nordisk, a pharmaceutical company in Denmark, said the price will drop 23% for WEGOVY of all doses on Wednesday. The new monthly price is immediately applied to $ 650 to $ 499.
NOVO said that the new price is provided to both people without insurance and those with insurance that do not guarantee weight loss drugs.
Last week, Eli Lilly said that the monthly price of the starter dose would be lowered to $ 349. The US pharmaceutical company also offers more doses for $ 499 through its own payment program.
The patient starts taking drugs that can be injectable at a smaller dose level, and then increases the amount over time.
Price cuts occur Consumables are improved. The American Food and Drug Administration shortened the two drugs from the list of medicines. The agency said that pharmacies and other organizations should stop production to other organizations that can make the brand’s inexpensive copies of the brand for a while.
Wegovy and Zepbound are part of the treatment of GLP-1 classes, which have shown unprecedented results that help people take weight by reducing appetite and full feeling. sale The drug has soared.
___
The AP Communication Health and Science Department is supported by the Science and Education Media Group and the Robert Wood Johnson Foundation of Howard Hughes Medical Research Institute. AP is entirely responsible for all content.
